Medical Aspects of Adverse Drug Reactions2018-10-24T16:26:03+00:00

Project Description

Medical Aspects of Adverse Drug Reactions 

Course overview

Venue: Solent Hotel, Whiteley, Fareham

Date: 05 June – 07 June 2019*

Adverse Drug Reactions (ADRs) are a major clinical problem. An understanding of the clinical aspects of ADRs is a fundamental requirement for any professional in the field of pharmacovigilance. The Medical Aspects of Adverse Drug Reactions course provides delegates with the opportunity to acquire concentrated instruction on the strategy of therapeutics, medical diagnosis and all medical aspects of ADRs. It is divided into individual body systems (such as hepatic, endocrine, haematological, neurological, psychiatric, cardiovascular, oncological, gastrointestinal, renal and respiratory) and general concepts of ADRs.

*Please note that the course dates and programme may be subject to change.

 Our courses are recognised by PharmaTrain.

Who should attend?

This course is aimed at:

  • Pharmaceutical industry personnel from areas including pharmacovigilance, clinical research, medical affairs,medical writing, regulatory affairs and medical information
  • Staff from regulatory authorities
  • Clinicians and academic staff
  • Pharmacists or other professions allied to medicines

Aims of course

  • To provide delegates with a grounding in, and analysis of, the core principles of medical diagnosis including pattern recognition and therapeutics
  • To analyse some of the core concepts of clinical pharmacology relevant to the conduct and interpretation of pharmacoepidemiological research
  • To review the mechanism of drug action, the concept of drug potency, the role of pharmacodynamics and pharmacokinetics (including genetic and immunological factors) in determining variability in drug response and drug interactions
  • To review the classification of ADRs and pathophysiology according to body system and associated public health burden

Learning Outcomes

On successful completion of this course delegates should be able to:

  • Analyse the complexity of undertaking medical diagnoses and the influence of human behaviour (prescriber and patient) and drug factors important in therapeutic decision making
  • Critically examine the important features associated with Type A and Type B reactions and identify factors associated with individual susceptibility
  • Appraise the rationale for performing clinical investigations and the importance of correct interpretation of results

Key Topics

Programmed features:

  • Principles of medical diagnosis
  • Comprehensive and up-to-date understanding of medical and scientific aspects of ADRs
  • ADR examples
  • Overview of ADR and interactions
  • Genetic and metabolic basis of ADRs
  • Immunological aspects of ADRs
  • ADRs by stem organ class
  • Regulatory aspects including guidelines and causality assessment

Fees

Cost Per Delegate:

£885 + VAT Academic

(Academic Units, Public Sector Organisations, Registered Charities)

Or

£1290 + VAT Standard

(Standard Registration)

Download Course Programme

Click here to download the programme

DOWNLOAD PROGRAMME

Booking options

Book now

TESTIMONIALS

“Dedicated and knowledgeable speakers, great facilities,and good planning and structure of course.”

Medical Aspects delegate May 2018

“Very interesting lectures. Good overall picture of ADR related issues”

Medical Aspects delegate May 2018

“All the speakers were so knowledgeable and the content was extremely good. Just the right level of information – not too complicated.”

Medical Aspects delegate May 2018

Excellent as always! Thoroughly enjoyed the course.

Medical Aspects delegate May 2017

Content was excellent – background and general knowledge covered but also more specific examples and conditions. Very qualified lecturers.”

Medical Aspects delegate January 2016

Course Leader

Dr Miranda Davies – Senior Clinical Research Fellow, BM, MFPM

Miranda qualified from Southampton Medical School in 1995. She completed Senior House Officer Posts in a variety of hospital specialties (Psychiatry, Elderly Care, Obstetrics and Gynaecology, Palliative Medicine). Miranda joined the DSRU in 2002 as a Clinical Research Fellow.

Miranda has worked primarily on Modified-Prescription Event Monitoring (M-PEM) and Specialist Cohort Event Monitoring (SCEM) studies, providing medical support. In November 2002, she was appointed Honorary Senior Lecturer at the University of Portsmouth, and has presented at international conferences, and published papers in peer reviewed journals. She is actively involved in teaching, facilitating and course organisation through DSRU Education and Research Limited, and was appointed Senior Clinical Research Fellow in 2010. She holds the Diploma in Pharmaceutical Medicine, and is a Member of the Faculty of Pharmaceutical Medicine (MFPM) of the Royal College of Physicians.

Contact Info

Drug Safety Research Unit Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, U.K.

Phone: +44 (0)23 80 40 86 00

Recent Posts